Does OMALIZUMAB Cause Transient ischaemic attack? 128 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 128 reports of Transient ischaemic attack have been filed in association with OMALIZUMAB (Omalizumab-igec). This represents 0.2% of all adverse event reports for OMALIZUMAB.
128
Reports of Transient ischaemic attack with OMALIZUMAB
0.2%
of all OMALIZUMAB reports
14
Deaths
65
Hospitalizations
How Dangerous Is Transient ischaemic attack From OMALIZUMAB?
Of the 128 reports, 14 (10.9%) resulted in death, 65 (50.8%) required hospitalization, and 14 (10.9%) were considered life-threatening.
Is Transient ischaemic attack Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OMALIZUMAB. However, 128 reports have been filed with the FAERS database.
What Other Side Effects Does OMALIZUMAB Cause?
No adverse event (9,736)
Asthma (9,354)
Urticaria (9,231)
Off label use (9,199)
Dyspnoea (8,323)
Drug ineffective (6,747)
Cough (5,926)
Pruritus (5,224)
Fatigue (5,053)
Malaise (4,820)
What Other Drugs Cause Transient ischaemic attack?
APIXABAN (1,157)
RIVAROXABAN (820)
LENALIDOMIDE (655)
ADALIMUMAB (604)
ASPIRIN (587)
ROSIGLITAZONE (585)
NAPROXEN (521)
LEVOTHYROXINE (517)
DABIGATRAN ETEXILATE (471)
CLOPIDOGREL BISULFATE (454)
Which OMALIZUMAB Alternatives Have Lower Transient ischaemic attack Risk?
OMALIZUMAB vs OMAVELOXOLONE
OMALIZUMAB vs OMBITASVIR
OMALIZUMAB vs OMBITASVIR\PARITAPREVIR\RITONAVIR
OMALIZUMAB vs OMEGA-3-ACID ETHYL ESTERS
OMALIZUMAB vs OMEGA-3-CARBOXYLIC ACIDS